D-0500-2025 Class II Ongoing

Recalled by Tailstorm Health INC — Phoenix, AZ

FDA drug recall D-0500-2025 was initiated by Tailstorm Health INC on Jun 2, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process. The recall status is ongoing. Affected quantity: 23,200 vials.

Recall details

Product Type
Drugs
Report Date
Jul 9, 2025
Initiation Date
Jun 2, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
23,200 vials

Product description

KETAmine Hydrochloride Injection, USP, 50 mg/5mL (10 mg/mL), For IM Use or Slow IV Use, 5 mL Sterile Single-Dose Vial, Rx Only, For Office Use Only, Compounded Durg by: Medivant Healthcare, 158 S. Kyrene Rd. Chandler, AZ 85226, NDC 81483-0006-0.

Reason for recall

Lack of Assurance of Sterility: A recent FDA inspection revealed concerns with the sterile manufacturing process.

Distribution pattern

Nationwide in the US

Code information

Lot #s: 2502008, Exp. 2/27/2027; 2503001, Exp. 3/4/2027.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0500-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0500-2025. Report a data issue: hello@regdatalab.com.